Global Symposium on Regulatory Science: Digital Transformation in "Regilatarl" Science
David Strauss, MD, PhD
CEO & Founder, Translational Cures | Former FDA Acting Chief Scientist
Last week I had the pleasure of joining my colleagues at FDA's National Center for Toxicological Research, who were hosting the Global Symposium on Regulatory Science Annual Conference. FDA Commissioner Robert Califf gave the opening remarks, and I gave the closing remarks.
Considering that this year's conference focused on "Digital Transformation in Regulatory Science" with sessions such as "Challenges and Opportunities for Artificial Intelligence in Regulatory Science" and "Is Regulatory Science Ready for AI", during the conference we uploaded the conference program into AI image generation software and asked it to make a summary image for the conference, which I shared in my closing remarks.
I think it is very impressive! I never could have come up with something so creative. And yet, on closer inspection, there are some peculiarities, most notably that the word regulatory is misspelled! I think this highlights the enormous potential of new technologies, while also the need to understand their limitations and context of use.
It was great to interact with the approximately 200 attendees at the conference, including 50 international attendees from 15 countries! Thank you to FDA's National Center for Toxicological Research for hosting such a great event!
Head Knowledge Innovation and Partnership management - EFSA
5 个月I’d like to extend my appreciation for the insightful discussions at the recent conference where I had the pleasure to contribute coming from the European regulatory science side. Indeed, as we continue to explore the transformative potential of AI and machine learning, it is essential to guarantee a human-centric approach when implementing the tools in our processes. Keeping people at the core allows us to fully leverage AI's capabilities while ensuring trust and integrity in their application. As discussed during the sessions, a collaborative approach, bridging innovation and regulation, is essential to ensuring that AI remains a ‘Tool’. In Europe the AI Act provides a regulatory beacon for the responsible and safe use of AI technologies, reflecting a shared commitment to innovation with integrity. Though if you boil it down to its essence, as you highlighted, the human centricity leading to accountability is the core.